Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for bovine-based collagen in tissue engineering and regenerative medicine
3.2.1.2 Increasing preference for bovine collagen-based hemostats in surgical procedures
3.2.1.3 Increasing growth in periodontal surgeries
3.2.2 Industry pitfalls & challenges
3.2.2.1 Concerns related to consistent supply of quality bovine-collagen
3.2.2.2 High cost involved in manufacturing bovine-based collagen products
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Wound dressing
5.3 Bone graft substitute
5.4 Collagen-based scaffold
5.5 Hemostat
5.6 Skin substitute
5.7 Cartilage repair
5.8 Other applications
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Baxter International, Inc.
8.2 BICO Group AB
8.3 botiss biomaterials GmbH
8.4 Collagen Solutions LLP
8.5 DSM
8.6 Encoll Corp.
8.7 Gurnet Point Capital (Innocoll Holdings plc)
8.8 Integra LifeSciences Corporation
8.9 Johnson & Johnson Services, Inc.
8.10 Medtronic plc
8.11 Regenity
8.12 Rousselot
8.13 SouthernBiotech
8.14 Symatese
8.15 Viscofan BioEngineering
